SEC 13F Intelligence

Capital Research Global Investors / CME

Capital Research Global Investors’s Cme Group Inc Position

Does Capital Research Global Investors own Cme Group Inc (CME)? Yes — 3.33M shares worth $985M (+0.15% of its 13F portfolio) as of Q1 2026, up from 1.06M shares the prior filed quarter.

Position Value
$985M
Q1 2026
Shares
3.33M
% of Portfolio
+0.15%
Quarters Held
30
currently held

Position History CME

Reported value by quarter
Q4 ’18: $2.1BQ4 ’18Q1 ’19: $2.0BQ2 ’19: $2.7BQ3 ’19: $2.8BQ4 ’19: $2.7BQ4 ’19Q1 ’20: $2.2BQ2 ’20: $1.8BQ3 ’20: $1.9BQ4 ’20: $2.0BQ4 ’20Q1 ’21: $2.0BQ2 ’21: $2.0BQ3 ’21: $1.6BQ4 ’21: $2.1BQ4 ’21Q1 ’22: $1.9BQ2 ’22: $1.4BQ3 ’22: $1.1BQ4 ’22: $1.0BQ4 ’22Q1 ’23: $1.6BQ2 ’23: $1.7BQ3 ’23: $1.8BQ4 ’23: $1.4BQ4 ’23Q1 ’24: $784MQ2 ’24: $529MQ3 ’24: $217MQ4 ’24: $178MQ4 ’24Q1 ’25: $204MQ2 ’25: $289MQ3 ’25: $285MQ4 ’25: $290MQ4 ’25Q1 ’26: $985Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.33M$985M+0.15%
Q4 20251.06M$290M+0.05%
Q3 20251.05M$285M+0.05%
Q2 20251.05M$289M+0.06%
Q1 2025767.9K$204M+0.04%
Q4 2024766.8K$178M+0.04%
Q3 2024981.6K$217M+0.05%
Q2 20242.69M$529M+0.12%
Q1 20243.64M$784M+0.18%
Q4 20236.59M$1.4B+0.34%
Q3 20239.00M$1.8B+0.50%
Q2 20239.17M$1.7B+0.46%
Q1 20238.22M$1.6B+0.45%
Q4 20225.95M$1.0B+0.30%
Q3 20226.11M$1.1B+0.36%
Q2 20226.60M$1.4B+0.42%
Q1 20227.84M$1.9B+0.46%
Q4 20219.10M$2.1B+0.46%
Q3 20218.50M$1.6B+0.38%
Q2 20219.30M$2.0B+0.46%
Q1 20219.81M$2.0B+0.49%
Q4 202011.14M$2.0B+0.53%
Q3 202011.14M$1.9B+0.56%
Q2 202011.30M$1.8B+0.58%
Q1 202012.56M$2.2B+0.85%
Q4 201913.60M$2.7B+0.82%
Q3 201913.35M$2.8B+0.93%
Q2 201913.82M$2.7B+0.85%
Q1 201912.06M$2.0B+0.63%
Q4 201811.42M$2.1B+0.75%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Capital Research Global Investors’s full portfolio or all institutional holders of CME.